Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Drug Competition Hearing Planned For Senate Commerce Cmte.

This article was originally published in The Tan Sheet

Executive Summary

The Senate Commerce Committee is tentatively planning to hold a hearing on anticompetitive practices affecting generic drug marketing in April or May

You may also be interested in...



Generic Reform Hearings Set In Senate, But McCain/Schumer Lacks Vehicle

Sen. Edward Kennedy (D-Mass.) has committed to generic drug reform hearings in the Health Committee this spring, Capitol Hill staffer Missy Rohrbach told the Generic Pharmaceutical Association annual meeting in Coral Gables, Fla. April 9

Generic Reform Hearings Set In Senate, But McCain/Schumer Lacks Vehicle

Sen. Edward Kennedy (D-Mass.) has committed to generic drug reform hearings in the Health Committee this spring, Capitol Hill staffer Missy Rohrbach told the Generic Pharmaceutical Association annual meeting in Coral Gables, Fla. April 9

Generic Reform Hearings Set In Senate, But McCain/Schumer Lacks Vehicle

Sen. Edward Kennedy (D-Mass.) has committed to generic drug reform hearings in the Health Committee this spring, Capitol Hill staffer Missy Rohrbach told the Generic Pharmaceutical Association annual meeting in Coral Gables, Fla. April 9

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel